HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Stephen E Kurtz Selected Research

vaccinia virus A52R protein

3/2005Identification of a peptide derived from vaccinia virus A52R protein that inhibits cytokine secretion in response to TLR-dependent signaling and reduces in vivo bacterial-induced inflammation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Stephen E Kurtz Research Topics

Disease

4Psoriasis (Pustulosis Palmaris et Plantaris)
02/2011 - 12/2007
3Infection
11/2010 - 12/2005
3Inflammation
10/2009 - 03/2005
2Hyperplasia
02/2011 - 11/2010
1Cutaneous Candidiasis
11/2010
1Candidiasis (Moniliasis)
11/2010
1Skin Diseases
10/2009
1Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
10/2009
1Atopic Dermatitis (Atopic Eczema)
05/2008
1Blister (Bulla)
01/2008
1Contagious Ecthyma (Orf)
01/2008
1Bacterial Infections (Bacterial Infection)
04/2004

Drug/Important Bio-Agent (IBA)

4interleukin-22 (IL-22)IBA
02/2011 - 12/2007
4CytokinesIBA
11/2010 - 12/2007
3Interleukin-17 (Interleukin 27)IBA
02/2011 - 12/2007
3Interleukin-23 (Interleukin 23)IBA
02/2011 - 12/2007
2Interleukin-12 (IL 12)IBA
11/2010 - 10/2009
2InterleukinsIBA
10/2009 - 09/2009
2DNA (Deoxyribonucleic Acid)IBA
01/2008 - 04/2004
1Monoclonal AntibodiesIBA
10/2009
1Transforming Growth Factor beta1 (TGF beta 1)IBA
10/2009
1Interleukin-23 Subunit p19IBA
10/2009
1AntigensIBA
05/2008
1efalizumabFDA Link
05/2008
1Viral DNAIBA
01/2008
1Immunoglobulin G (IgG)IBA
01/2008
1DC-specific ICAM-3 grabbing nonintegrin (DC-SIGN)IBA
12/2005
1C-Type Lectins (C-Type Lectin)IBA
12/2005
1vaccinia virus A52R proteinIBA
03/2005

Therapy/Procedure

1Injections
02/2011